Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Halo Labs has raised $7.0M in total funding. The most recent round was Series C. The last funding was announced in July 2022.
Halo Labs's investors include National Science Foundation, BioAdvance, Agilent Technologies, BroadOak Capital Partners, Ben Franklin Technology Partners of Southeastern Pennsylvania.
Halo Labs is headquartered in Philadelphia, United States.
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Halo Labs is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Halo Labs — Funding & Investors." VCBacked, July 8, 2022, https://www.vcbacked.co/company/halo-labs. Accessed October 1, 2026.
VCBacked. (2022). Halo Labs — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/halo-labs
{{cite web |title=Halo Labs — Funding & Investors |url=https://www.vcbacked.co/company/halo-labs |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated